Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice

Jpn J Surg. 1985 Mar;15(2):173-6. doi: 10.1007/BF02469749.

Abstract

We investigated the synergistic anti-tumor effects of K-18 (conjugate of human gamma-globulin and melphalan) and concomitantly administered hyperthermia on Lewis lung carcinoma in mice. The antitumor effect of a subeffective dose of K-18 or an equivalent dose of melphalan alone was enhanced by local hyperthermia. K-18 administration demonstrated a greater potentiation for inhibition of tumor growth than that of melphalan alone. Local hyperthermia plus K-18 reduced the dose of melphalan required for tumor growth inhibition by melphalan alone. The combined application of K-18 and hyperthermia for treating cancer warrants further study.

MeSH terms

  • Animals
  • Carcinoma / therapy*
  • Combined Modality Therapy
  • Drug Combinations / metabolism
  • Drug Combinations / therapeutic use
  • Female
  • Humans
  • Hyperthermia, Induced*
  • Immunotoxins*
  • Lung Neoplasms / therapy*
  • Melphalan / metabolism
  • Melphalan / therapeutic use*
  • Mice
  • Tissue Distribution
  • gamma-Globulins / metabolism
  • gamma-Globulins / therapeutic use*

Substances

  • Drug Combinations
  • Immunotoxins
  • K-18 conjugate
  • gamma-Globulins
  • Melphalan